FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump warns UK it’s ‘very dangerous’ to do business with China after Starmer’s Beijing meeting

Trump administration eases sanctions on Venezuelan oil industry after Maduro’s capture

Video: Anti-ICE Agitators Say Video of Woman Writhing in Pain Shows ICE Blew Part of Her Hand Off, But Look What We Found When We Slowed It Down

CNN’s Navarro Calls Pretti ‘Perfect Guy’ She’d Want Daughter to Date Before Disturbing New Video Surfaces

Dems provide Republicans key votes to advance Trump-backed funding package

Hunter Biden Argues He’s Not Legally Obligated to Communicate with His 7-Year-Old Daughter in New Court Filing

Trump files $10B lawsuit against IRS over alleged tax return leaks to major news outlets

Social justice advocate once named Bostonian of the Year sentenced in fraud case

Man Arrested While Allegedly Attempting to Break Luigi Mangione Out of Prison by Posing as an FBI Agent

Judges weigh Title IX funding fight over Virginia schools’ pro-transgender bathroom policies

Anti-ICE agitators mistake TSA air marshals for ICE agents, heckle them at Los Angeles-area restaurant

‘Zizian’ suspect to represent self at trial as other associates derail murder case

Dem Governor’s Attempt to Frame JD Vance’s Holocaust Remembrance Day Post as Anti-Semitic Backfires

Virginia Democrats seek dozens of new tax hikes, including on dog walking and dry cleaning

FIRST ON FOX: FEMA unleashes $2.2B in disaster relief funding across 25 states: ‘Cutting red tape’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”